Gene-expression profiling in Parkinson’s disease: discovery of valid biomarkers, molecular targets and biochemical pathways

By Papapetropoulos Spiridon   McCorquodale Donald  

Future Neurology, Vol. 2, Iss. 1, 2007-01 ,pp. : 29-38

Future Medicine

Access to resources Recommend Favorite

Parkinson’s disease: oxidative stress and therapeutic approaches

By Surendran Sankar   Rajasankar Srinivasagam  

Neurological Sciences, Vol. 31, Iss. 5, 2010-10 ,pp. : 531-540

Springer Publishing Company

Access to resources Recommend Favorite

Tetrahydrobiopterin Availability in Parkinson’s and Alzheimer’s Disease; Potential Pathogenic Mechanisms

By Foxton Richard   Land John   Heales Simon  

Neurochemical Research, Vol. 32, Iss. 4-5, 2007-04 ,pp. : 751-756

Springer Publishing Company

Access to resources Recommend Favorite

Gonadotropins: potential targets for preventive and therapeutic interventions in Alzheimer’s disease

By Barron Anna M   Verdile Giuseppe   Martins Ralph N  

Future Neurology, Vol. 1, Iss. 2, 2006-03 ,pp. : 189-202

Future Medicine

Access to resources Recommend Favorite

Melatonin in Parkinson's disease

By Medeiros C.  

Journal of Neurology, Vol. 255, Iss. 5, 2008-05 ,pp. : 759-759

Springer Publishing Company

Access to resources Recommend Favorite